Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Cancer-specific mutations in PIK3CA are oncogenic in vivo

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Bader, A. G.
  • Kang, S. Y.
  • Vogt, Peter K.

publication date

  • January 2006

journal

  • Proceedings of the National Academy of Sciences of the United States of America  Journal

abstract

  • The PIK3CA gene, coding for the catalytic subunit p110alpha of class IA phosphatidylinositol 3-kinases (PI3Ks), is frequently mutated in human cancer. Mutated p110alpha proteins show a gain of enzymatic function in vitro and are oncogenic in cell culture. Here, we show that three prevalent mutants of p110alpha, E542K, E545K, and H1047R, are oncogenic in vivo. They induce tumors in the chorioallantoic membrane of the chicken embryo and cause hemangiosarcomas in the animal. These tumors are marked by increased angiogenesis and an activation of the Akt pathway. The target of rapamycin inhibitor RAD001 blocks tumor growth induced by the H1047R p110alpha mutant. The in vivo oncogenicity of PIK3CA mutants in an avian species strongly suggests a critical role for these mutated proteins in human malignancies.

subject areas

  • Animals
  • Antineoplastic Agents
  • Blotting, Western
  • Cell Membrane
  • Cells, Cultured
  • Chick Embryo
  • Chickens
  • Chorioallantoic Membrane
  • Disease Models, Animal
  • Hemangiosarcoma
  • Humans
  • Microglia
  • Mutation
  • Neoplasms
  • Phosphatidylinositol 3-Kinases
  • Placebos
  • Signal Transduction
  • Sirolimus
  • Time Factors
  • Transfection
scroll to property group menus

Research

keywords

  • 3-kinase
  • chorioallantoic membrane
  • hemangiosarcoma
  • p110
  • phosphaticlylinositol
scroll to property group menus

Identity

PubMed Central ID

  • PMC1360603

International Standard Serial Number (ISSN)

  • 0027-8424

Digital Object Identifier (DOI)

  • 10.1073/pnas.0510857103

PubMed ID

  • 16432179
scroll to property group menus

Additional Document Info

start page

  • 1475

end page

  • 1479

volume

  • 103

issue

  • 5

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support